We also check for any health issues that might make GLP-1 meds unsafe for you, such as a history of pancreatitis, thyroid cancer, or some digestive problems
Foundayo, the new oral GLP-1, will be covered starting June 1
311 (1), R124R132
Most healthcare providers of our team recommend regular follow-up appointments to assess tolerance and effectiveness
In a small 2023 study on the effect of semaglutide on obese PCOS patients who did not see improvement with lifestyle changes alone, 80% of participants lost at least 5% of their body weight over three months [3]
Giugliano D, Scappaticcio L, Longo M, Caruso P, Maiorino MI, Bellastella G, Ceriello A, Chiodini P, Esposito K